Notch is out

Learn more ↗

Industry top-down

Medical Instruments & Supplies

Latest reported revenue & EPS across the covered companies in this industry, with year-over-year (YoY) change. From disclosed earnings — not investment advice.

28 companiesMedian revenue YoY: +8.0%EPS beat rate: —

AI industry top-down

The medical device and supplies industry showed overall moderate growth, recording a median revenue growth rate of approximately 3.5%. However, individual company performance was largely mixed. Some companies, such as Intuitive Surgical and Lemaitre Vascular, achieved double-digit revenue growth, demonstrating strong performance. In contrast, others, including Becton Dickinson and Align Technology, experienced revenue declines. Earnings per share (EPS) also showed significant company-specific variations, with both positive growth and substantial declines coexisting.

  • Industry median sales growth rate recorded 3.5%
  • Some companies achieved robust double-digit sales growth
  • Many companies experienced sales declines and EPS decreases
  • Significant variation in EPS growth rates across companies
Where companies diverge: Revenue Growth Rate: Some companies show double-digit growth, while others decline. · EPS Growth Rate: Some companies show high growth, while others experience a significant decline.

AI synthesis of disclosed results and analyst research across these companies — not investment advice.

Companies — latest quarter

CompanyPeriodRevenueRev YoYEPSEPS YoYSurprise
ISRGINTUITIVE SURGICAL INCFY2026 Q2$2.89B+18.5%$2.29+26.5%—
BDXBECTON DICKINSON & COFY2026 Q3$4.98B-9.5%$1.37-31.5%—
MDLNMedline Inc.FY2026 Q2$7.69B—$0.07——
RSMDFRESMED INCFY2026 Q3$1.43B+10.8%$2.74+10.5%—
RMDRESMED INCFY2026 Q3$1.43B+10.8%$2.74+10.5%—
WSTWEST PHARMACEUTICAL SERVICES INCFY2026 Q2$872.3M+13.8%$2.15+18.1%—
SOLVSolventum CorpFY2026 Q2$2.21B+2.2%$0.53+3.9%—
BAXBAXTER INTERNATIONAL INCFY2026 Q2$2.96B+5.3%$0.24+33.3%—
COOCOOPER COMPANIES, INC.FY2026 Q3$1.07B+0.6%$2.24——
ALGNALIGN TECHNOLOGY INCFY2026 Q2$1.06B+4.3%$1.51-12.2%—
AVTRAvantor, Inc.FY2026 Q1$1.58B0.0%$0.06-33.3%—
ATRAPTARGROUP, INC.FY2026 Q2$1.03B+6.3%$1.36-18.6%—
BLCOBausch & Lomb CorpFY2026 Q2$1.39B+9.1%$-0.04——
MMEDMiniMed Group, Inc.FY2027 Q1$843M—$0.00——
MMSIMERIT MEDICAL SYSTEMS INCFY2026 Q2$418.84M+9.5%$0.65+20.4%—
TFXTELEFLEX INCFY2026 Q2$570.33M-27.0%$2.28-17.7%—
ICUIICU MEDICAL INC/DEFY2026 Q2$551.68M+0.5%$0.76-46.9%—
NVSTEnvista Holdings CorpFY2026 Q2$730.5M+7.1%$0.33+106.3%—
PLSEPULSE BIOSCIENCES, INC.FY2022 Q3$0—$-0.49——
WRBYWarby Parker Inc.FY2026 Q2$235.51M+9.8%$0.04——
ATRCAtriCure, Inc.FY2026 Q2$153.6M+12.8%$0.18——
XRAYDENTSPLY SIRONA Inc.FY2026 Q2$898M-4.1%$0.18——
LMATLEMAITRE VASCULAR INCFY2024 Q3$54.82M—$0.49——
KMTSKESTRA MEDICAL TECHNOLOGIES, LTD.FY2027 Q1$30.97M+59.9%$-0.75——
AZTAAzenta, Inc.FY2026 Q3$161.18M+12.0%$0.05——
STAASTAAR SURGICAL COFY2027 Q2$93.54M+111.0%$0.16——
ANGOANGIODYNAMICS INCFY2026 Q3$78.42M+8.9%$-0.19——
EMBCEmbecta Corp.FY2026 Q3$271.7M-8.1%$0.36-53.8%—

YoY = vs. the same quarter last year · Surprise = EPS actual vs. consensus. Latest reported quarter per company, from disclosed earnings filings. QoQ is omitted because quarterly filings don’t break out Q4 (US) and report cumulatively (KR).

We use cookies and similar technologies for analytics, to understand how the site is used. You can accept or decline non-essential cookies. See our Privacy Policy.